NasdaqGS - Nasdaq Real Time Price USD

Inogen, Inc. (INGN)

Compare

9.64

-0.04

(-0.41%)

At close: December 11 at 4:00:01 PM EST

9.64

0.00

(0.00%)

After hours: December 11 at 4:01:53 PM EST

5 Medical Device Stocks That Survived the 2024 Market Volatility

Here, we discuss five medical device stocks, namely ISRG, GMED, GKOS, VCYT and INGN, which gained in 2024 despite ongoing challenges and provide an attractive investment opportunity for 2025.

Zacks 16 hours ago

VCYT

GKOS
+4.77%
INGN
-0.41%
Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Inogen (INGN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Zacks 16 days ago

INGN
-0.41%
INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up

Inogen's overall third-quarter 2024 results continue to gain from higher business-to-business sales.

Zacks 30 days ago

INGN
-0.41%
RMD

BSX
US$10.00 - That's What Analysts Think Inogen, Inc. (NASDAQ:INGN) Is Worth After These Results

A week ago, Inogen, Inc. ( NASDAQ:INGN ) came out with a strong set of third-quarter numbers that could potentially...

Simply Wall St. last month

INGN
-0.41%
Inogen Third Quarter 2024 Earnings: Beats Expectations

Inogen ( NASDAQ:INGN ) Third Quarter 2024 Results Key Financial Results Revenue: US$88.8m (up 5.8% from 3Q 2023). Net...

Simply Wall St. last month

INGN
-0.41%
Inogen (INGN) Reports Q3 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks last month

INGN
-0.41%
Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC Challenges

Inogen Inc (INGN) reports robust business-to-business revenue growth and improved profitability, despite declines in direct-to-consumer sales.

GuruFocus.com last month

INGN
-0.41%
Inogen (INGN) Reports Q3 Loss, Tops Revenue Estimates

Inogen (INGN) delivered earnings and revenue surprises of 50.98% and 6.16%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

INGN
-0.41%
Inogen: Q3 Earnings Snapshot

INGN) on Thursday reported a loss of $6 million in its third quarter. The Goleta, California-based company said it had a loss of 25 cents per share. The results surpassed Wall Street expectations.

Associated Press Finance last month

INGN
-0.41%
Inogen Announces Third Quarter 2024 Financial Results

GOLETA, Calif., November 07, 2024--Inogen Announces Third Quarter 2024 Financial Results

Business Wire last month

INGN
-0.41%
Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations

New leadership appointments strengthen Sight Sciences’ commitment to advancing innovative eyecare solutions and supporting scalable operations and growthMENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today the appointment of MK Raheja, Ph.D. as its Executive Vic

GlobeNewswire last month

SGHT

INGN
-0.41%
Inogen, Inc. (INGN): A Bear Case Theory

We came across a bearish thesis on Inogen, Inc. (INGN) on Substack by The Nexus Files. In this article, we will summarize the bears’ thesis on INGN. Inogen, Inc. (INGN)’s share was trading at $9.57 as of Nov 6th. INGN’s trailing P/E was 98.76 according to Yahoo Finance. Inogen, a company that sells lightweight oxygen concentrators for […]

Insider Monkey last month

INGN
-0.41%
Inogen to Present at Upcoming Investor Conferences

GOLETA, Calif., November 04, 2024--Inogen to Present at Upcoming Investor Conferences

Business Wire last month

INGN
-0.41%
Here's Why You Should Retain Inogen Stock in Your Portfolio Now

Expanding product portfolio and high prospects for POC raise optimism for INGN stock.

Zacks last month

INGN
-0.41%
Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024

GOLETA, Calif., October 17, 2024--Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024

Business Wire last month

INGN
-0.41%
Inogen Inc (INGN) Q2 2024 Earnings Call Highlights: Strong B2B Growth Amid DTC Challenges

Inogen Inc (INGN) reports a 6% revenue increase, driven by robust business-to-business performance, despite a decline in direct-to-consumer sales.

GuruFocus.com 2 months ago

INGN
-0.41%
Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC

GOLETA, Calif., October 08, 2024--Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC

Business Wire 2 months ago

INGN
-0.41%
Inogen Stock Rises 47% in 6 Months: What's Driving the Rally?

INGN shows impressive momentum, driven by strong sales growth, an expanding product portfolio and significant advancements in portable oxygen technology.

Zacks 2 months ago

INGN
-0.41%
Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business

Just because a business does not make any money, does not mean that the stock will go down. Indeed, Inogen...

Simply Wall St. 2 months ago

INGN
-0.41%
Here's Why You Should Add Inogen Stock to Your Portfolio Now

Expanding product portfolio and high prospects for POC raise optimism for the INGN stock.

Zacks 2 months ago

INGN
-0.41%

Performance Overview

Return	INGN	S&P 500
YTD	+75.59%	+27.56%
1-Year	+62.29%	+32.14%
3-Year	-72.04%	+29.12%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Inogen, Inc. (INGN)

5 Medical Device Stocks That Survived the 2024 Market Volatility

Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up

US$10.00 - That's What Analysts Think Inogen, Inc. (NASDAQ:INGN) Is Worth After These Results

Inogen Third Quarter 2024 Earnings: Beats Expectations

Inogen (INGN) Reports Q3 Earnings: What Key Metrics Have to Say

Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC Challenges

Inogen (INGN) Reports Q3 Loss, Tops Revenue Estimates

Inogen: Q3 Earnings Snapshot

Inogen Announces Third Quarter 2024 Financial Results

Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations

Inogen, Inc. (INGN): A Bear Case Theory

Inogen to Present at Upcoming Investor Conferences

Here's Why You Should Retain Inogen Stock in Your Portfolio Now

Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024

Inogen Inc (INGN) Q2 2024 Earnings Call Highlights: Strong B2B Growth Amid DTC Challenges

Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC

Inogen Stock Rises 47% in 6 Months: What's Driving the Rally?

Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business

Here's Why You Should Add Inogen Stock to Your Portfolio Now

Performance Overview